Description: Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India. The company provides polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, and dimethyl 5-aminoisophthalate, as well as 3,5-dinitrobenzoic acid and 3,5-diamino benzoic acid. It also offers drug intermediates comprising 2-acetyl thiophene, thiophene-2-carboxaldehyde, 4"amino pyridine, and 2"chloro"5"nitrobenzoic acid. In addition, the company exports its products. Arvee Laboratories (India) Ltd. was incorporated in 2012 and is based in Ahmedabad, India.
Home Page: arveelabs.com
403, Entice Building
Ahmedabad,
380 058
India
Phone:
91 27 1743 0479
Officers
| Name | Title |
|---|---|
| Mr. Shalin Sudhakarbhai Patel | Chairman & MD |
| Mr. Saurin Ajitbhai Gandhi | Chief Financial Officer |
| Ms. Raina Singh Chauhan | Company Sec. & Compliance Officer |
| Mr. Shalin Bharatbhai Chokshi | Whole-Time Director |
Exchange: NSE
Country: IN : India
Currency: Indian Rupee (INR)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 28.5459 |
| Price-to-Book MRQ: | 5.1077 |
| Price-to-Sales TTM: | 2.6007 |
| IPO Date: | |
| Fiscal Year End: | March |
| Full Time Employees: | 66 |